Literature DB >> 15123168

The IGF-I system component concentrations that decrease with ageing are lower in obesity in relationship to body mass index and body fat.

José Manuel Gómez1, Francisco Javier Maravall, Núria Gómez, Miguel Angel Navarro, Roser Casamitjana, Juan Soler.   

Abstract

The aim of this study was to investigate the GH-IGF-I axis in healthy adults and its relationship to obesity. We studied 268 subjects: 134 men and 134 women, and determined anthropometric and body composition variables. Serum total IGF-I was measured by radioimmunoassay, serum free IGF-I concentrations by enzyme linked immunosorbant assay and serum IGFBP3 concentrations by radioimmunoassay. In men, we observed a decrease in total IGF-I, free IGF-I and IGFBP-3 throughout decades. In women, the body mass index and fat mass were higher throughout decades, and we observed a similar decrease to that in men in total IGF-I, free IGF-I and IGFBP3. In men with obesity, as measured by body fat, free IGF-I concentrations were lower than those without obesity; in women with obesity, total IGF-I concentrations and free IGF-I concentrations were lower than in those with obesity. These changes were observed in relationship to obesity when the subjects were adjusted for differences in age. We showed that in controls randomly selected, the GH-IGF-I axis component concentrations that decrease with increasing age are lower in obesity, especially in women, and that this decrease is related to body mass index and body fat.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15123168     DOI: 10.1016/j.ghir.2003.11.004

Source DB:  PubMed          Journal:  Growth Horm IGF Res        ISSN: 1096-6374            Impact factor:   2.372


  16 in total

1.  IGF-I polymorphism is associated with lean mass, exercise economy, and exercise performance among premenopausal women.

Authors:  Mardya López-Alarcón; Gary R Hunter; Barbara A Gower; José R Fernández
Journal:  Arch Med Res       Date:  2006-11-03       Impact factor: 2.235

2.  Vitamin D status may contribute to serum insulin-like growth factor I concentrations in healthy subjects.

Authors:  F Bogazzi; G Rossi; M Lombardi; L Tomisti; C Sardella; L Manetti; O Curzio; C Marcocci; L Grasso; M Gasperi; E Martino
Journal:  J Endocrinol Invest       Date:  2010-07-29       Impact factor: 4.256

3.  Characteristics of adult patients with growth hormone deficiency who underwent neurosurgery for functioning and non-functioning pituitary adenomas and craniopharyngiomas.

Authors:  R Baldelli; A Bianchi; F Diacono; M Passeri; A Fusco; D Valle; M Poggi; M Terlini; V Toscano; G Tamburrano; A Pontecorvi; G Maira; L De Marinis
Journal:  J Endocrinol Invest       Date:  2005-02       Impact factor: 4.256

4.  The relationships between IGF-1 and CRP, NO, leptin, and adiponectin during weight loss in the morbidly obese.

Authors:  Eva Pardina; Roser Ferrer; Juan Antonio Baena-Fustegueras; Albert Lecube; Jose Manuel Fort; Víctor Vargas; Roberto Catalán; Julia Peinado-Onsurbe
Journal:  Obes Surg       Date:  2010-05       Impact factor: 4.129

5.  Spuriously Elevated Serum IGF-1 in Adult Individuals with Delayed Puberty: A Diagnostic Pitfall.

Authors:  Syed Ali Imran; Michael Pelkey; David B Clarke; Dale Clayton; Peter Trainer; Shereen Ezzat
Journal:  Int J Endocrinol       Date:  2010-08-30       Impact factor: 3.257

6.  Regulation of bone mineral density in morbidly obese women: a cross-sectional study in two cohorts before and after bypass surgery.

Authors:  José Manuel Gómez; Núria Vilarrasa; Carles Masdevall; Jordi Pujol; Esther Solano; Juan Soler; Iñaki Elio; Lluis Gallart; Joan Vendrell
Journal:  Obes Surg       Date:  2008-04-29       Impact factor: 4.129

7.  Bioactive insulin-like growth factor-I in obesity.

Authors:  J Frystyk; D J Brick; A V Gerweck; A L Utz; K K Miller
Journal:  J Clin Endocrinol Metab       Date:  2009-05-26       Impact factor: 5.958

8.  Preoperative prediction of growth hormone (GH)/insulin-like growth factor-1 (IGF-1) axis modification and postoperative changes in candidates for bariatric surgery.

Authors:  Francesco Mittempergher; Giacomo Pata; Nicola Crea; Ernesto Di Betta; Antonio Vilardi; Deborah Chiesa; Riccardo Nascimbeni
Journal:  Obes Surg       Date:  2013-05       Impact factor: 4.129

9.  IGFBP-3 inhibits cytokine-induced insulin resistance and early manifestations of atherosclerosis.

Authors:  Lathika Mohanraj; Ho-Seong Kim; Wei Li; Qing Cai; Ki Eun Kim; Hye-Jung Shin; Yong-Jae Lee; Woo Jung Lee; Jung Hyun Kim; Youngman Oh
Journal:  PLoS One       Date:  2013-01-28       Impact factor: 3.240

10.  Association of decreased sperm motility and increased seminal plasma IGF-I, IGF-II, IGFBP-2, and PSA levels in infertile men.

Authors:  Li Fu; Kevin C J Yuen; Aye Nyein Tint; Andrew R Hoffman; Ariff T Bongso; Kok Onn Lee
Journal:  Endocrine       Date:  2021-07-17       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.